[#DIV28SUPER] Call for Nominations - APA Advisory Steering Committee for Development of Clinical Practice Guidelines

Dear Division 28 colleagues,

 

Apologies for cross-posting. Please forward the following announcement to your networks.

 

Thank you,

Jacob

Psychologist sought for position on APA clinical practice guideline advisory steering committee

Deadline for nominations is April 1, 2022

Nominations are invited for one position on the Advisory Steering Committee for Development of Clinical Practice Guidelines of the American Psychological Association (APA). The Advisory Steering Committee (ASC) oversees APA's process for clinical practice guideline development, including selection of topics for guidelines, recommendation of members for guideline development panels, and planning and assessment of guideline development processes. The term for the new position will begin in spring 2022, and the deadline for submitting nominations is April 1, 2022. Individuals are asked to self-nominate.

It is preferred, though not required, that the psychologist filling the open position have substantial background in at least one of the following areas:

• Direct provision of psychological care in diverse practice settings or with diverse populations.
• Child and/or family-focused clinical or research expertise.
• Older adult-focused clinical or research expertise.
• Direct provision of clinical treatment or services in the areas of mental health, physical health or health behaviors.
• Behavioral medicine.
• Health care financing.
• Use of guidelines within systems or by direct providers.
• Dissemination or implementation research.
• Primary care work experience.
• Expertise in intervention research (including efficacy and change processes).
• Expertise in quantitative research methods (especially, clinical trials and other methods for causal inference).
• Expertise in qualitative (including mixed) research methods and synthesis of qualitative findings.

Psychologists from a variety of perspectives and orientations (e.g., psychodynamic, cognitive-behavioral, family systems, humanistic) are encouraged to apply.  Psychologists with experience providing interventions to, conducting research with, or implementing clinical practice guidelines with diverse populations are especially encouraged to apply.

Work of the Advisory Steering Committee

So far, APA has developed and adopted three clinical practice guidelines in the areas of treatment of PTSD in adults (2017), obesity and overweight in children and adolescents (2018), and depression across the lifespan (2019).  There are currently two active guideline development panels: one on the treatment of chronic musculoskeletal pain and another on updating APA’s (2017) clinical practice guideline for treatment of PTSD in adults.

With assistance from APA staff, the work of the Advisory Steering Committee (ASC) includes: 

1. Design and assessment of the policies and procedures by which APA develops clinical practice guidelines.
2. Selection of topics for development of clinical practice guidelines.
3. Recommendations to the APA Board of Directors of individuals to serve on clinical practice guideline development panels.
4. Formulation of policies for commissioning and utilizing independent systematic reviews of empirical research to inform the development of clinical practice guidelines.
5. Planning the structure and format of guideline documents and related products.
6. Designing strategies for enhancing the dissemination and implementation of clinical practice guidelines.
7. Evaluation of the effectiveness and impacts of clinical practice guidelines.
8. Provision of progress reports to the Board of Directors and other APA governance groups. 

Over the next several years, the ASC will select new topics for guideline development and recommend members of guideline development panels for those topics. The ASC will also design strategies for disseminating APA guidelines, encouraging their implementation by health care providers and organizations, and evaluating their impact. Further, the ASC aims to build relationships with other organizations to collaborate in developing and disseminating clinical practice guidelines.  The ASC provides direction to APA's overall efforts in clinical practice guideline development but does not itself engage in the writing of guidelines or the conduct of systematic reviews.

The ASC reports to the Board of Directors, with additional oversight by the Board of Professional Affairs and Board of Scientific Affairs. Staff from the APA Practice Directorate and Science Directorate support the ASC's activities.

As currently authorized, the ASC has positions for ten individuals. Each member serves for a term of three years, with the possibility of renewal for a second term. All future work of the ASC is contingent on APA policy and funding.

During their tenure, ASC members are expected to:

• Attend up to three extended meetings (with each meeting being either two full days in person in Washington, D.C. or a series of half-day virtual meetings) per year. These may include meetings of the ASC and/or meetings of guideline development panels.  Travel expenses for any in-person meetings are paid by APA.
• Participate in monthly 1.5-hour conference calls and review materials between calls.
• Engage in communication with ASC colleagues and APA staff via email.
• Serve on at least one sub-group of the ASC (e.g., topic selection sub-committee, dissemination and implementation sub-committee).

Current Membership

The current members of the ASC are:

• Jamile Ashmore

Baylor Scott & White The Heart Hospital – Plano

 

• Marni Axelrad

Texas Children’s Hospital – Houston

 

• Anil Chacko

New York University

 

• Claire Collie (Chair)

Veterans Affairs Central Office

 

• Brandon Gaudiano

Butler Hospital

 

• David Haaga

American University

 

• Evan Mayo-Wilson

Indiana University – Bloomington

 

• J. Christopher Muran

Adelphi University

 

• Stacy Ogbeide

University of Texas Health Science Center, San Antonio

 

• Jacqueline B. Persons

Oakland Cognitive Behavior Therapy Center

Nomination Process and Review

All nominees should have 5 or more years of professional experience in clinical practice or clinical research (or combination thereof) and documented expertise in the general arena of evidence-based treatment development or implementation. Additionally, nominees should be nationally recognized via publications, professional awards, advanced credentials, involvement in professional organizations, and the like. Nominations of individuals who will enhance the diversity of the ASC are encouraged. Nominees should be members of the APA. However, current members of the Board of Directors, Board of Professional Affairs, and Board of Scientific Affairs are not eligible to serve on the ASC.

Nominees' materials will be reviewed initially by the ASC and by the Board of Professional Affairs and Board of Scientific Affairs.  A list of candidates will be submitted to the Board of Directors for it to make final selections and appointments. 

Review will include attention to nominees' areas of expertise, as well as their experience working with diverse patient populations (across race, ethnicity, language, gender, gender identity, sexual orientation, age, disability, class status, education, religious/spiritual orientation, and other cultural dimensions, as well as adult, adolescent and child patient populations) and within various clinical settings.

Nomination materials should include: 

• Letter from the nominee indicating willingness to serve a three-year term.
• Brief statement (up to three pages) of the nominee's expertise and qualifications related to the criteria described above. 
• Nominee’s current curriculum vitae.

Nomination materials should be submitted by the nominees themselves. Endorsements from other individuals or groups are not expected. 

Nomination materials should be sent via email (cpg@apa.org) by April 1, 2022. In the event of questions or difficulties regarding email transmissions, please contact Project Manager for APA’s Clinical Practice Guidelines, Jacob Marzalik, MA, by email (jmarzalik@apa.org). 

Questions about the call and about APA's development of clinical practice guidelines can be directed to Raquel Halfond, PhD, Senior Director, Evidence Based Practice & Health Equity, via email (rhalfond@apa.org).

 

 

Jacob S. Marzalik, MA (he/him/his)

Project Manager, Clinical Practice Guidelines

Practice Transformation and Quality, Practice Directorate

American Psychological Association

  

750 First Street NE, Washington DC 20002-4242

202-336-5872

 

All APA staff are teleworking until further notice and are experiencing a high volume of inquiries related to COVID-19. For immediate information and resources, visit APA's COVID-19 page for psychologists, health-care workers, and the public.

 

[#DIV28SUPER] NIDA Neuroscience Update January 24, 2022

I.                     Advancing technologies to improve delivery of pharmacological, gene editing, and other cargoes for HIV and SUD mechanistic or therapeutic research (R01- Clinical Trial Optional) RFA-DA-22-010

II.                   Accelerating the Pace of Drug Abuse Research Using Existing Data RFA-DA-22-037 and RFA-DA-22-028

III.                 Upcoming Funding Opportunity on Workshops on Computational and   Analytical Research Methods

 

------------

I.                    Advancing technologies to improve delivery of pharmacological, gene editing, and other cargoes for HIV and SUD mechanistic or therapeutic research (R01- Clinical Trial Optional) RFA-DA-22-010

The purpose of this funding opportunity is to develop technologies to improve the delivery of pharmacological, gene editing, or other cargoes for HIV and SUD mechanistic research.

-----

II.                 Accelerating the Pace of Drug Abuse Research Using Existing Data RFA-DA-22-037 and RFA-DA-22-028

R01 - https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-037.html

R21 - https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-038.html

 

Next Application deadline: March 4, 2022

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of substance using behaviors (defined as alcohol, tobacco, prescription, and other substances) and related disorders, prevention of substance use and HIV, and health service utilization. This FOA encourages the analyses of public use and other extant community-based or clinical datasets to their full potential in order to increase our knowledge of etiology, trajectories of substance using behaviors and their consequences including morbidity and mortality, risk and resilience in the development of psychopathology, strategies to guide the development, testing, implementation, and delivery of high quality, effective and efficient services for the prevention and treatment of substance use disorder and HIV. Primary data collection is not allowed for applications in response to this FOA.

Posted Date: January 10, 2022

Funds Available and Anticipated Number of Awards: NIDA intends to commit $2 million in FY 2022 to fund 3-5 awards.

 

III.               Upcoming Funding Opportunity on Workshops on Computational and   Analytical Research Methods

 

The NIDA concept below may be of interest to you. FYI, a concept “describes the purpose, scope, and objectives of a potential funding opportunity. Concepts are posted to give interested researchers additional time to plan for application submissions. Approved concepts are usually developed into Requests For Applications (RFAs), Program Announcements that include set-aside funds (PASs), or Program Announcements with special receipt, referral and/or review considerations (PARs). The NACDA conducts most, but not all, NIDA concept clearances. Concepts may also be cleared through other public venues.”

Please feel free to share among your colleagues.

Workshops on Computational and Analytical Research Methods

Posted September 2021

Background

Neurocognitive studies have undergone transformative changes over the last decade. First, there has been a shift in the field towards pooling together smaller datasets (e.g., ENIGMA) or creating larger ones that are widely disseminated (e.g., Human Connectome Project, ABCD, HBCD). This shift has accelerated machine learning-based efforts towards prediction of substance use and psychiatric outcomes. Second, computational psychiatry has witnessed significant advances in explanatory modeling that seek to uncover neural computations underlying cognition, behavior, and associated dysfunction (e.g., reinforcement learning models applied towards dopamine’s role in reward learning and motivation). While major advancements have been made in the development of rigorous analytical and computational methods, their application in SUD research remains an area for further growth.

Goal

The purpose of this concept is to invite applications that disseminate analytical and computational methodologies and best practices through educational activities with hands-on research experience. The overall goals of this initiative are:

1. Facilitating collaboration between clinical and computational researchers on SUD research
2. Enhancing rigor and reproducibility towards better predictive models
3. Broader application of sophisticated analytical and computational modeling approaches in SUD research
4. Development of novel solutions to challenges faced in clinical application of computational psychiatry models

Primary: Vani Pariyadath, Ph.D., Chief, Behavioral and Cognitive Neuroscience Branch, Division of Neuroscience and Behavior

Elizabeth Hoffman, Ph.D., Scientific Program Manager (ABCD Project), Division of Extramural Research

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L

 

[#DIV28SUPER] Seeking Nominations for the APA Board of Convention Affairs

Dear Colleagues,

 

We are seeking nominations for the APA Board of Convention Affairs (BCA). Here is a description of the role of BCA from the APA website:

 

"It shall be the responsibility of the Board of Convention Affairs to recommend policies and procedures to be followed in planning the Annual Convention, to coordinate the programs of Divisions and other organized groups within the Association, and to arrange for programs of general interest at the time of the annual convention."

 

Attached please find a description of what we are looking for in new members, members' responsibilities and the link where nominations are accepted. Nominations of self or others are accepted.

 

I am a member of BCA, so am happy to answer questions from any interested individuals.

 

Best,

 

Rob Leeman

 

 

Robert F. Leeman, Ph.D.
Associate Professor 

Mary F. Lane Endowed Professor 

Department of Health Education and Behavior 

College of Health and Human Performance 

Co-Director, NIH/NIAAA T32: Translational Science Training to Reduce the Impact of Alcohol on HIV Infection 

Associate Director, Southern HIV & Alcohol Research Consortium (SHARC) 

University of Florida 

Florida Gymnasium, Room 14 

PO Box 118210     Gainesville, FL  32611 

Phone: (352) 294-1808 

Email: robert.leeman@ufl.edu 

Faculty webpage: Robert Leeman, Ph.D. - College of Health and Human Performance (ufl.edu)

Lab webpage: EDGE Lab - College of Health and Human Performance (ufl.edu)

Twitter:@LeemanRobertF

 

[#DIV28SUPER] Postdoctoral Fellow in Substance Use Disorder Research, University of Vermont, Vermont Center in Behavior and Health

The Vermont Center on Behavior and Health located at the Larner College of Medicine, University of Vermont announces a NIH (T32) postdoctoral research fellowship opportunity in our internationally-recognized center of excellence for substance use disorder research. The fellow will help will help to lead ongoing research involving pregnant and non-pregnant women with opioid and other substance use disorders. Applicants must have completed their training in psychology or a related discipline, be U.S. citizens or permanent residents, and have a commitment to a career substance use disorder research. For more information and to apply visit our website.

Stephen T. Higgins, Ph.D.

Director, Vermont Center on Behavior and Health

Virginia H. Donaldson Professor in Translational Science

Departments of Psychiatry and Psychological Science

University of Vermont

1 South Prospect Street, OH3, MS482

Burlington, VT  05401

VCBH Administrative Assistant: Susan Enos
susan.enos@uvm.edu

802-656-9615

[#DIV28SUPER] 2-Year Postdoc Position at Davidson College

The Behavioral Pharmacology Laboratory at Davidson College invites applications for a 2-year postdoctoral position in the Department of Psychology. The successful applicant will join an NIH-funded laboratory examining behavioral and pharmacological factors contributing to substance abuse using animal models (e.g., drug self-administration). Candidates must have a PhD or equivalent degree in pharmacology, neuroscience, or psychology, and experience with animal models of behavior. Ideal candidates will have a background in the experimental analysis of behavior with basic expertise in neuroscience and pharmacology. The person accepting this position will play a role in overseeing two NIH-funded projects, and typical activities will include (but will not be limited to), collecting data, writing manuscripts, presenting data at scientific conferences, and preparing extramural grants. Teaching may be an option for those with interest, but it is not a requirement of the position.

 

Interested candidates should apply via this link and searching for "postdoctoral fellow" under "staff": https://www.davidson.edu/offices-and-services/human-resources/work-davidson

 

Inquires may be made to Mark Smith at masmith@davidson.edu. Davidson College is a highly selective, nationally recognized, Liberal Arts College located 20 minutes north of Charlotte, North Carolina. We are an equal opportunity employer and encourage applications from diverse populations.

 

**********************************

Mark Smith, PhD

Wayne M. & Carolyn A. Watson Professor

Department of Psychology

Program in Neuroscience

Davidson College

 

Office: Wall 392

Phone: 704-894-2470

Website: www.davidson.edu/academics/psychology/faculty-and-staff/mark-smith

US Postal Mailing Address: Mark Smith | Department of Psychology | Davidson College | Davidson, NC 28035

Courier Shipping Address: Mark Smith | Department of Psychology | 209 Ridge Road | Davidson College | Davidson, NC 28035

 

 

 

 

 

[#DIV28SUPER] Decision Aids for Clinical Practice Guidelines Now Available!

 

Decision Aids for Clinical Practice Guidelines Now Available!

 

APA recently published a set of decision aids to accompany each of its existing clinical practice guidelines (PTSD in Adults, Obesity and Overweight in Children and Adolescents, and Depression in Children/Adolescents, Adults, and Older Adults). The decision aids are intended to facilitate shared decision-making within evidence-based practice in psychology. It is hoped that the decision aids will serve as a concise and helpful resource for practitioners seeking to integrate APA’s CPGs into their broader evidence-based work.

 

Please share widely with your networks. 

 

 

Jacob S. Marzalik, MA (he/him/his)

Project Manager, Clinical Practice Guidelines

Practice Transformation and Quality, Practice Directorate

American Psychological Association

  

750 First Street NE, Washington DC 20002-4242

202-336-5872

 

All APA staff are teleworking until further notice and are experiencing a high volume of inquiries related to COVID-19. For immediate information and resources, visit APA's COVID-19 page for psychologists, health-care workers, and the public.

 

[#DIV28SUPER] Upcoming NIH HEAL RFAs

Dear Colleagues,

 

As part of the NIH HEAL Initiative, the National Institute on Drug Abuse (NIDA) is releasing a set of interrelated RFAs to create the HEAL Data2Action (HD2A) Program, a coordinated effort to promote the synthesis and real-world application of existing data to guide and monitor improvements in service delivery to prevent or treat opioid use disorder (OUD) and pain. Collectively, these projects will address gaps in the delivery of evidence-based practices in each of the four pillars of the HHS Overdose Prevention Strategy: primary prevention, harm reduction, treatment of opioid use disorder, and recovery support.

 

The HD2A program includes four related funding opportunity announcements:

• HEAL D2A Innovation Grants (R61/R33, March 10 due date) (RFA-DA-22-051) 
• HEAL D2A Data Infrastructure Support Center (U24, March 10 due date) (RFA-DA-22-052) 
• HEAL D2A Modeling and Economic Resource Center (U24, March 10 due date) (RFA-DA-22-049) 
• HEAL D2A Research Adoption Support Center (U2C, March 25 due date) (RFA-DA-22-050) 

 

Potential applicants are strongly encouraged to consult with NIDA Program staff early in the application development process. This early contact will provide an opportunity to discuss and clarify NIH policies and guidelines, including the scope of the project relative to the HEAL initiative mission and intent of this FOA. Inquiries may be emailed to: HEALdata2action@nih.gov. A technical assistance webinar for applicants to the Data2Action initiative will be held on January 24th, 2022 at 2 pm EST. Registration is required: https://www.drugabuse.gov/news-events/meetings-events/2022/01/pre-application-information-webinar-heal-data2action-program

 

 

 

Barbara A. Oudekerk/Maurer, Ph.D.

Program Officer |Lead Project Scientist, HEAL Prevention Initiative

Prevention Research Branch

Division of Epidemiology, Services and Prevention Research (DESPR)

National Institute on Drug Abuse | NIH

barbara.oudekerk@nih.gov  | barbara.maurer@nih.gov | (301) 827-0641

Pronouns: she/her/hers

[#DIV28SUPER] Passing of Richard Saitz

All,

Sorry to share that Richard Saitz, friend to many in Division 28, has passed after a battle with pancreatic cancer.  Dr. Saitz was a Professor of Medicine and Public Health at Boston University and a very accomplished scholar, clinician and journal editor.  He published over 200 peer-reviewed papers, helped validate clinical assessment tools used for screening and brief intervention for substance use disorders, and was Editor-in-Chief for the Journal of Addiction Medicine and Associate Editor for the Journal of the American Medical Association.

An online memorial portal has been set up for him where friends and colleagues can post messages to the Saitz family for those inclined to do so.

https://www.dignitymemorial.com/obituaries/brookline-ma/richard-saitz-10531193

This is a terrible loss to the field and yet another reminder to make our time here count.  

Condolences to the Saitz family on behalf of Division 28.

Regards,

-Ryan

Ryan Vandrey, PhD

President

American Psychological Association

Division 28

[#DIV28SUPER] Fwd: [SCIENCECHANNEL] APA Seeks Input on 2 RFIs from Biden Administration

FYI

Begin forwarded message:

From: "Prinstein, Mitch" <MPrinstein@apa.org>

Subject: [SCIENCECHANNEL] APA Seeks Input on 2 RFIs from Biden Administration

Date: January 14, 2022 at 3:58:54 PM EST

To: SCIENCECHANNEL@LISTS.APA.ORG

Reply-To: Forum for urgent science needs with the APA Science and Advocacy Offices <SCIENCECHANNEL@LISTS.APA.ORG>

      External Email - Use Caution      

The American Psychological Association (APA) is preparing responses for two Requests for Information (RFIs) from the Biden Administration on timely research issues relevant to our communities (below). 1) The White House Office of Science and Technology Policy requests feedback on how health technologies can improve community-level wellness and health equity. 2) The National Institutes of Health solicits comments on the strategic plan for the NIH Chief Officer for Scientific Workforce Diversity.

 

1. RFI for the White House OSTP

APA seeks your input in responding to a RFI on Strengthening Community Health Through Technology from the White House Office of Science and Technology Policy (OSTP). OSTP requests input from community health stakeholders, technology developers, and other interested parties about how digital health technologies are used, or could be used in the future, to transform community health, individual wellness, and health equity. They are particularly interested in information from community-based health settings and about populations traditionally underserved by healthcare. Social, behavioral, and psychological science can contribute significantly to their understanding.

 

APA seeks your input to inform our response to this request from OSTP and interested individuals should submit comments electronically via this web form February 7^th. Contributions will be collected and incorporated in APA's response to the White House.

 

 

2. RFI for the National Institutes of Health

APA seeks your input in responding  a request for information from the NIH Chief Officer for Scientific Workforce Diversity (COSWD) team on its Draft NIH Chief Officer for Scientific Workforce Diversity Strategic Plan for FYs 2022-2026 soliciting comments. "The purpose of the COSWD Strategic Plan for FYs 2022-2026 is to communicate how the COSWD will advance its mission to be the agency's thought leader in the science of scientific workforce diversity, using evidence-based approaches to catalyze cultures of inclusive excellence." COSWD anticipates releasing it in spring 2022.

 

The Plan describes its three goals—to build, disseminate, and act on the evidence to advance scientific workforce diversity—and corresponding objectives and tactics to achieve each of these goals. It also articulates how the COSWD will leverage three cross-cutting strategies—collaborations, accountability, and evaluation—to pursue its efforts across all three goals. The deadline for contributing to the APA response is February 4th. Please submit any suggestions/recommendations you have for the NIH RFI to the following form. We look forward to your input.

 

Click on this link to unsubscribe from the SCIENCECHANNEL list UNSUBSCRIBE

An email will automatically open with "Unsubscribe" in the subject area. Just Send the message, as is, to unsubscribe from this list.